GLP-1RA intervention was not associated with the changes in total cholesterol levels when compared to those given metformin or placebo (MD = 0.03
Gastrointestinal symptoms: Some peptides, especially GLP-1 receptor agonists such as semaglutide or tirzepatide, can slow digestion, which may lead to nausea, vomiting, diarrhea, or constipation
If you or someone you know is struggling with body image or eating concerns, the National Eating Disorders Association's toll-free and confidential helpline is available by phone or text at 1-800-931-2237 or by click-to-chat message at nationaleatingdisorders.org/helpline
Appetite remains reduced but you're learning what portions work for your new normal
Statements Author contributions AJ: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Visualization, Writing original draft, Writing review & editing